A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Diffuse Large B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yuqin Song) · songyuqin622@163.com · +86-010-88140650
Contact: Principal Investigator (Yuqin Song)
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Zhiming Li) · lzmlzmlzm@yahoo.com · +86-020-87343392
Contact: Principal Investigator (Zhiming Li)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Clonal Cytopenia of Undetermined Significance · High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements · Recurrent Diffuse Large B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Mankato, United States · Rochester, United States

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

Lymphoma · Lymphoma, Large B-Cell, Diffuse

Abroad (travel likely)RecruitingPHASE2

Miami, United States · Boston, United States

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Diffuse Large B-Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE2

Tianjin, China

A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Beijing, China